Lincoln Pharmaceuticals informs about disclosure

29 Feb 2024 Evaluate

Lincoln Pharmaceuticals has informed that it enclosed the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Renukaben Maheshbhai Patel.

The above information is a part of company’s filings submitted to BSE.

Lincoln Pharma Share Price

566.00 13.85 (2.51%)
15-Apr-2025 12:51 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1707.70
Dr. Reddys Lab 1146.30
Cipla 1468.20
Lupin 2000.20
Zydus Lifesciences 876.35
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...